Who attended? View the participant list.
Day 1: Hilton Cape Town City Centre
Monday, 29 September 2014
Douglas Keene, Vice President, Center for Pharmaceutical Management, MSH
Opening remarks from host country and partner organizations
|9:00–11:15 a.m.||A) UHC and Medicines | Plenary session
Facilitator: Professor Aggrey Ambali, Director, African Science, Technology, and Innovation, NEPAD
Rapporteur: Evans Sagwa, MSH/Namibia
|9:00–9:20 a.m.||Expanding access to health care and medicines in Southern African countries; UHC aspirational goals (Precious Matsoso, National Department of Health)|
|9:20–9:40 a.m.||Importance of medicines in the health system and UHC; stakeholders and their roles and responsibilities (Kees de Joncheere, World Health Organization)|
|9:40–10:15 a.m.||Panel discussion: Perspectives from three Southern Africa countries in relation to medicines benefits and efforts toward UHC
|10:30–11:00 a.m.||Medicines benefits management: An overview of MSH’s user guide, results of assessment in Namibia, and status of assessment in South Africa (Kwesi Eghan, MSH)|
|11:15–12:30 p.m.||B) Medicines Benefits Design & Management | Plenary session
Facilitator: Pamela Kauseni, Ministry of Finance, Planning & Budgeting, Zambia
Rapporteur: Bada Pharasi, MSH/South Africa
|11:15–11:35 a.m.||Designing & managing medicines benefits – goals, policy options, ethical considerations (Anita Wagner, Harvard University)|
|11:35–11:55 a.m.||Designing and managing medicines benefits – estimating costs; operational and governance considerations (Anban Pillay, National Department of Health, South Africa)|
|11:55–12:15 p.m.||Designing and managing medicines benefits – experiences and partnerships with the private sector (Roger Wiseman, Liberty Health, South Africa)|
|12:30–1:30 p.m.||Lunch Break|
|1:30–4:45 p.m.||Facilitated Group Discussions – Part I|
|1:30–1:40 p.m.||Introduction Participants will be broken into three small discussion groups for Part I and two for Part II of the facilitated conversations. At each of the discussion centers, each group will discuss an overarching topic and up to three (3) sub-topics. At each center there will be a facilitator and a rapporteur who will serve as group hosts. At 40 or 45 minute intervals, participant groups will move to the next discussion center.Group hosts remain at the same discussion center for all discussion groups, and will summarize the previous discussion to the next group of participants. This ensures input on each topic by all participants, building on each other’s contributions and connections of new ideas across topics in each discussion center. After all rotations, each participant will have had an opportunity to contribute to each topic.The discussion group facilitators and rapporteurs then summarize each of the overarching topics in a plenary session and participants draw conclusions.|
|1:40–2:20 p.m.||Topics B1, B2, and B3|
|2:20–3:00 p.m.||Topics B1, B2, and B3|
|3:00–3:40 p.m.||Topics B1, B2, and B3|
|B1) How to determine medicines benefits policy and program needs?
Facilitator/presenter: Jane Robertson, WHO
Rapporteur: Milli Reddy, MSH/South Africa
B2) How can medicines benefits be sustainably and equitably financed?
B3) What are key aspects of managing a medicines benefits program?
|4:00–4:45 p.m.||Facilitated Group Discussions SummaryFacilitators/presenters: Break-out group facilitatorsRapporteurs: Break-out group rapporteurs
|4:45–5:45 p.m.||C) Information for decision making | Plenary session
Facilitator: Kofi Aboagye-Nyame, MSH
Rapporteur: Stephanie Berrada, MSH/South AfricaTo ensure wise use of limited resources, emerging and expanding insurance schemes must monitor what they spend money on, and how much money they are spending. Medicines are key factors for achieving the goals of UHC, and the main reasons for inefficiency in spending. It is therefore crucial to monitor key indicators of medicines in health systems using the existing data and to strive toward information technology that facilitates the processes.
|4:45–5:05 p.m.||Working towards generating information routinely for medicines benefits management – A system framework (Dennis Ross-Degnan, Harvard University)|
|5:05–5:25 p.m.||The critical role of evolving information systems and the need for standardized coding – An example (Christo Rademan, Mediscor, South Africa)|
|Close of Day 1|
Day 2: Hilton Cape Town City Centre
Tuesday, 30 September 2014
|8:15–8:30 a.m.||Re-cap of Day 1|
|8:30–9:30 a.m.||Multiple-stakeholder partnerships for medicines benefits in moving towards UHC Panel Session
Facilitator: David Lee, MSH
Rapporteur: Jafary Liana, MSH/TanzaniaDiscussants:
|9:30–12 noon||Facilitated Group Discussions – Part II|
|9:30–10:15 a.m.||Topics C1 and C2|
|10:15–11:00 a.m.||Topics C1 and C2|
|C1) What information is needed to inform medicines benefits decisions?
Facilitator/presenter: Anita Wagner, Harvard University
Rapporteur: Stephanie Berrada, MSH/South Africa
C2) What characteristics of systems are needed to generate information for medicines benefits policy and program decisions?
|11:15–12 noon||Facilitated Group Discussions Summary
Facilitators/presenters: Break-out group facilitators
Rapporteurs: Break-out group rapporteurs
|12:00–1:00 p.m.||Closing and farewell
Facilitator: Gilles Forte, WHO
Rapporteur: Catherine Vialle-Valentin, Harvard UniversityCountry response:
|Close of Day 2|